Concepts (233)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Scorpion Venoms | 7 | 2021 | 7 | 1.490 |
Why?
|
| Computer Simulation | 4 | 2021 | 53 | 1.000 |
Why?
|
| Genetics, Population | 2 | 2021 | 50 | 0.940 |
Why?
|
| Protein Interaction Maps | 2 | 2020 | 3 | 0.930 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2023 | 9 | 0.890 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2023 | 25 | 0.880 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2021 | 11 | 0.770 |
Why?
|
| Genome, Human | 1 | 2021 | 24 | 0.760 |
Why?
|
| Host-Parasite Interactions | 1 | 2020 | 2 | 0.750 |
Why?
|
| Protozoan Proteins | 1 | 2020 | 3 | 0.750 |
Why?
|
| Phenotype | 1 | 2021 | 144 | 0.750 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 190 | 0.750 |
Why?
|
| Proteomics | 1 | 2020 | 13 | 0.740 |
Why?
|
| Plasmodium falciparum | 1 | 2020 | 63 | 0.720 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 12 | 0.720 |
Why?
|
| Betacoronavirus | 1 | 2020 | 51 | 0.700 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 84 | 0.680 |
Why?
|
| Viper Venoms | 5 | 2017 | 7 | 0.650 |
Why?
|
| Neoplasm Invasiveness | 3 | 2018 | 9 | 0.640 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2018 | 11 | 0.600 |
Why?
|
| Humans | 27 | 2024 | 14077 | 0.580 |
Why?
|
| Peptides | 5 | 2019 | 40 | 0.570 |
Why?
|
| Glioma | 1 | 2016 | 1 | 0.560 |
Why?
|
| Antineoplastic Agents | 4 | 2021 | 61 | 0.510 |
Why?
|
| Animals | 16 | 2021 | 1063 | 0.480 |
Why?
|
| Amino Acid Sequence | 10 | 2020 | 139 | 0.480 |
Why?
|
| Cell Proliferation | 5 | 2021 | 43 | 0.450 |
Why?
|
| Pharmacogenetics | 2 | 2024 | 27 | 0.440 |
Why?
|
| Cell Line, Tumor | 9 | 2019 | 70 | 0.430 |
Why?
|
| Phospholipases A2 | 3 | 2017 | 5 | 0.430 |
Why?
|
| Models, Molecular | 7 | 2019 | 84 | 0.430 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 2 | 2022 | 7 | 0.410 |
Why?
|
| Computational Biology | 2 | 2024 | 43 | 0.400 |
Why?
|
| Whole Genome Sequencing | 2 | 2021 | 40 | 0.370 |
Why?
|
| Molecular Docking Simulation | 6 | 2020 | 36 | 0.350 |
Why?
|
| Binding Sites | 2 | 2020 | 43 | 0.320 |
Why?
|
| Melanoma | 2 | 2018 | 8 | 0.310 |
Why?
|
| Scorpions | 4 | 2021 | 4 | 0.300 |
Why?
|
| Colonic Neoplasms | 2 | 2019 | 7 | 0.300 |
Why?
|
| Viperidae | 3 | 2017 | 4 | 0.290 |
Why?
|
| Bacterial Proteins | 2 | 2019 | 117 | 0.280 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 20 | 0.270 |
Why?
|
| Mutation, Missense | 2 | 2023 | 65 | 0.270 |
Why?
|
| Protein Conformation | 5 | 2021 | 24 | 0.260 |
Why?
|
| Genomics | 2 | 2024 | 106 | 0.240 |
Why?
|
| WT1 Proteins | 1 | 2024 | 1 | 0.240 |
Why?
|
| Databases, Genetic | 2 | 2021 | 20 | 0.230 |
Why?
|
| Software | 1 | 2024 | 36 | 0.230 |
Why?
|
| Integrin alphaVbeta3 | 3 | 2018 | 3 | 0.230 |
Why?
|
| Protein Interaction Mapping | 2 | 2020 | 2 | 0.230 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2019 | 326 | 0.230 |
Why?
|
| Africa South of the Sahara | 2 | 2021 | 328 | 0.220 |
Why?
|
| Neoplasms | 3 | 2020 | 141 | 0.220 |
Why?
|
| Alleles | 1 | 2023 | 134 | 0.210 |
Why?
|
| Haplotypes | 1 | 2023 | 119 | 0.210 |
Why?
|
| Phylogeny | 2 | 2020 | 231 | 0.210 |
Why?
|
| Molecular Dynamics Simulation | 3 | 2018 | 25 | 0.210 |
Why?
|
| Sequence Alignment | 6 | 2019 | 59 | 0.200 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2019 | 3 | 0.200 |
Why?
|
| Receptors, Formyl Peptide | 1 | 2021 | 3 | 0.200 |
Why?
|
| Receptors, Lipoxin | 1 | 2021 | 3 | 0.200 |
Why?
|
| Glioblastoma | 1 | 2021 | 3 | 0.200 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 7 | 0.200 |
Why?
|
| Up-Regulation | 1 | 2021 | 23 | 0.200 |
Why?
|
| Breast Neoplasms | 1 | 2024 | 128 | 0.200 |
Why?
|
| Oligopeptides | 1 | 2021 | 16 | 0.200 |
Why?
|
| Escherichia coli | 2 | 2019 | 30 | 0.200 |
Why?
|
| Pandemics | 2 | 2023 | 280 | 0.200 |
Why?
|
| Hydroxychloroquine | 1 | 2021 | 5 | 0.190 |
Why?
|
| Apoptosis | 5 | 2020 | 39 | 0.190 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2021 | 7 | 0.190 |
Why?
|
| Chloroquine | 1 | 2021 | 10 | 0.190 |
Why?
|
| Antigens, Viral | 1 | 2021 | 19 | 0.190 |
Why?
|
| Viral Proteins | 1 | 2021 | 30 | 0.190 |
Why?
|
| Viral Vaccines | 1 | 2021 | 21 | 0.190 |
Why?
|
| Proteome | 1 | 2020 | 4 | 0.190 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 7 | 0.190 |
Why?
|
| Cell Adhesion | 5 | 2019 | 18 | 0.190 |
Why?
|
| Salmonella enteritidis | 1 | 2020 | 1 | 0.190 |
Why?
|
| Salmonella Infections | 1 | 2020 | 3 | 0.190 |
Why?
|
| Machine Learning | 1 | 2020 | 19 | 0.180 |
Why?
|
| Molecular Typing | 1 | 2020 | 12 | 0.180 |
Why?
|
| Malaria, Falciparum | 1 | 2020 | 39 | 0.180 |
Why?
|
| Protein Domains | 1 | 2020 | 10 | 0.180 |
Why?
|
| Protein Structure, Tertiary | 1 | 2020 | 22 | 0.180 |
Why?
|
| Genotype | 1 | 2021 | 430 | 0.170 |
Why?
|
| Protein Binding | 2 | 2016 | 62 | 0.170 |
Why?
|
| Pichia | 1 | 2019 | 2 | 0.170 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2019 | 10 | 0.170 |
Why?
|
| Arthropod Venoms | 1 | 2019 | 1 | 0.170 |
Why?
|
| Channelopathies | 1 | 2019 | 1 | 0.170 |
Why?
|
| Arthropod Proteins | 1 | 2019 | 1 | 0.170 |
Why?
|
| Prostatic Neoplasms | 1 | 2019 | 29 | 0.170 |
Why?
|
| Kaempferols | 1 | 2019 | 1 | 0.160 |
Why?
|
| Fluorouracil | 1 | 2019 | 19 | 0.160 |
Why?
|
| Epitopes | 1 | 2019 | 97 | 0.160 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 70 | 0.160 |
Why?
|
| Disintegrins | 1 | 2018 | 1 | 0.160 |
Why?
|
| Integrin alpha1beta1 | 1 | 2018 | 1 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 102 | 0.160 |
Why?
|
| Mucus | 1 | 2018 | 2 | 0.160 |
Why?
|
| Potassium Channel Blockers | 1 | 2018 | 1 | 0.150 |
Why?
|
| Shaker Superfamily of Potassium Channels | 1 | 2018 | 1 | 0.150 |
Why?
|
| Kv1.3 Potassium Channel | 1 | 2018 | 1 | 0.150 |
Why?
|
| Lectins, C-Type | 1 | 2017 | 2 | 0.150 |
Why?
|
| Molecular Sequence Data | 5 | 2017 | 263 | 0.150 |
Why?
|
| Sea Bream | 1 | 2017 | 1 | 0.150 |
Why?
|
| Africa | 3 | 2024 | 360 | 0.140 |
Why?
|
| Fish Proteins | 1 | 2017 | 1 | 0.140 |
Why?
|
| Arginine | 1 | 2016 | 5 | 0.140 |
Why?
|
| Brain Neoplasms | 1 | 2016 | 6 | 0.140 |
Why?
|
| Phospholipids | 1 | 2016 | 13 | 0.140 |
Why?
|
| Genetic Variation | 3 | 2022 | 169 | 0.130 |
Why?
|
| Neovascularization, Pathologic | 1 | 2016 | 4 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2016 | 14 | 0.130 |
Why?
|
| Down-Regulation | 1 | 2016 | 22 | 0.130 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2015 | 1 | 0.130 |
Why?
|
| Kinetics | 4 | 2017 | 65 | 0.130 |
Why?
|
| Antigens, Bacterial | 1 | 2015 | 32 | 0.130 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2014 | 1 | 0.120 |
Why?
|
| Fusarium | 1 | 2014 | 1 | 0.120 |
Why?
|
| Phospholipases | 1 | 2014 | 3 | 0.120 |
Why?
|
| Fungal Proteins | 1 | 2014 | 5 | 0.120 |
Why?
|
| Shal Potassium Channels | 1 | 2014 | 1 | 0.120 |
Why?
|
| Dopaminergic Neurons | 1 | 2014 | 1 | 0.120 |
Why?
|
| Neuropeptides | 1 | 2014 | 2 | 0.120 |
Why?
|
| L-Amino Acid Oxidase | 1 | 2014 | 1 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 3 | 2019 | 13 | 0.110 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2012 | 6 | 0.110 |
Why?
|
| Cell Movement | 3 | 2018 | 11 | 0.100 |
Why?
|
| Mice | 3 | 2018 | 134 | 0.100 |
Why?
|
| Cloning, Molecular | 3 | 2019 | 26 | 0.100 |
Why?
|
| Substrate Specificity | 3 | 2017 | 4 | 0.100 |
Why?
|
| Developing Countries | 2 | 2024 | 385 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 2 | 2023 | 24 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2020 | 33 | 0.090 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2019 | 27 | 0.080 |
Why?
|
| Cell Survival | 2 | 2019 | 45 | 0.080 |
Why?
|
| Carcinogenesis | 2 | 2018 | 4 | 0.080 |
Why?
|
| Protein Multimerization | 2 | 2019 | 8 | 0.070 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2019 | 2 | 0.070 |
Why?
|
| Virulence Factors | 2 | 2019 | 18 | 0.070 |
Why?
|
| Tunisia | 2 | 2020 | 3 | 0.070 |
Why?
|
| Glycosylation | 2 | 2019 | 17 | 0.070 |
Why?
|
| Gene Expression | 2 | 2019 | 43 | 0.070 |
Why?
|
| Recombinant Proteins | 2 | 2019 | 72 | 0.070 |
Why?
|
| Molecular Weight | 2 | 2017 | 13 | 0.070 |
Why?
|
| Hydrolysis | 2 | 2016 | 3 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2024 | 1 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2024 | 5 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2024 | 48 | 0.060 |
Why?
|
| Base Sequence | 2 | 2014 | 149 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2014 | 180 | 0.050 |
Why?
|
| Male | 3 | 2019 | 6489 | 0.050 |
Why?
|
| Cross Protection | 1 | 2021 | 4 | 0.050 |
Why?
|
| BCG Vaccine | 1 | 2021 | 20 | 0.050 |
Why?
|
| Rare Diseases | 1 | 2020 | 5 | 0.050 |
Why?
|
| Minisatellite Repeats | 1 | 2020 | 3 | 0.050 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2020 | 10 | 0.050 |
Why?
|
| Foodborne Diseases | 1 | 2020 | 6 | 0.050 |
Why?
|
| Algorithms | 1 | 2020 | 105 | 0.040 |
Why?
|
| Serogroup | 1 | 2020 | 134 | 0.040 |
Why?
|
| NAV1.6 Voltage-Gated Sodium Channel | 1 | 2019 | 1 | 0.040 |
Why?
|
| Sodium Channels | 1 | 2019 | 6 | 0.040 |
Why?
|
| Protein Conformation, beta-Strand | 1 | 2019 | 3 | 0.040 |
Why?
|
| Protein Folding | 1 | 2019 | 4 | 0.040 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2019 | 4 | 0.040 |
Why?
|
| Mycobacterium bovis | 1 | 2019 | 4 | 0.040 |
Why?
|
| Receptors, Growth Factor | 1 | 2019 | 1 | 0.040 |
Why?
|
| Ion Channels | 1 | 2019 | 3 | 0.040 |
Why?
|
| Mutation | 1 | 2020 | 299 | 0.040 |
Why?
|
| Phenols | 1 | 2019 | 4 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2019 | 54 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 27 | 0.040 |
Why?
|
| Melanins | 1 | 2018 | 1 | 0.040 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2018 | 1 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 137 | 0.040 |
Why?
|
| Potassium | 1 | 2018 | 25 | 0.040 |
Why?
|
| Cisplatin | 1 | 2017 | 5 | 0.040 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2017 | 10 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2017 | 4 | 0.040 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2017 | 4 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 9 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2017 | 20 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2017 | 7 | 0.040 |
Why?
|
| Enzyme Stability | 1 | 2017 | 1 | 0.040 |
Why?
|
| Fishes | 1 | 2017 | 3 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2017 | 26 | 0.040 |
Why?
|
| Risk Factors | 1 | 2021 | 1431 | 0.040 |
Why?
|
| Integrin beta1 | 1 | 2016 | 1 | 0.030 |
Why?
|
| Chickens | 1 | 2016 | 5 | 0.030 |
Why?
|
| Colon | 1 | 2016 | 8 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 12 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2016 | 4 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 23 | 0.030 |
Why?
|
| Xenopus | 1 | 2015 | 1 | 0.030 |
Why?
|
| Oocytes | 1 | 2015 | 2 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2015 | 14 | 0.030 |
Why?
|
| Betaine | 1 | 2015 | 1 | 0.030 |
Why?
|
| Detergents | 1 | 2015 | 2 | 0.030 |
Why?
|
| Cell Death | 1 | 2015 | 2 | 0.030 |
Why?
|
| Virulence | 1 | 2015 | 25 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2015 | 39 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 34 | 0.030 |
Why?
|
| Onions | 1 | 2014 | 1 | 0.030 |
Why?
|
| Galactolipids | 1 | 2014 | 1 | 0.030 |
Why?
|
| Enzyme Assays | 1 | 2014 | 1 | 0.030 |
Why?
|
| Lipase | 1 | 2014 | 3 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2014 | 5 | 0.030 |
Why?
|
| Plant Leaves | 1 | 2014 | 12 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2014 | 61 | 0.030 |
Why?
|
| Substantia Nigra | 1 | 2014 | 1 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2014 | 1 | 0.030 |
Why?
|
| Gene Library | 1 | 2014 | 2 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 6 | 0.030 |
Why?
|
| Sequence Homology | 1 | 2014 | 11 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 12 | 0.030 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2014 | 1 | 0.030 |
Why?
|
| Chromatography, Gel | 1 | 2014 | 4 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2014 | 6 | 0.030 |
Why?
|
| Chromatography, Affinity | 1 | 2014 | 8 | 0.030 |
Why?
|
| Sequence Analysis, Protein | 1 | 2014 | 10 | 0.030 |
Why?
|
| Microscopy, Video | 1 | 2012 | 1 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2012 | 1 | 0.030 |
Why?
|
| Lethal Dose 50 | 1 | 2012 | 3 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 2012 | 17 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2012 | 10 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 6 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 16 | 0.030 |
Why?
|
| DNA Primers | 1 | 2012 | 55 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 124 | 0.030 |
Why?
|
| Female | 1 | 2024 | 8751 | 0.020 |
Why?
|
| Tuberculosis | 1 | 2015 | 530 | 0.020 |
Why?
|